Clinical Trials in Tennessee

Showing 6081-6100 of 20,239 trials

Brain Tissue Specimen Collection

NCT00593203

The Molecular Neurosurgical Tissue Bank will function as a tissue or specimen repository for biopsy specimens from patients (both adult and pediatric) undergoing brain surgery and brain procedures.

Brain Diseases

Vanderbilt University Medical Center2,500 participantsStarted May 2003

Nashville, Tennessee, United States

Enrolling By InvitationNA29 miles

Effects of a Virtual Reality Intervention on Mental Health Outcomes and Academic Success in Physical Therapy Students

NCT06567496

Exploring the impact of a virtual reality program, First Resort on graduate physical therapy student wellness and academic success.

Mental StressAnxietyDepression+1 more

Belmont University23 participantsStarted Aug 2024

Nashville, Tennessee, United States

COMPLETEDPhase 229 miles

Open-Label Study of Setmelanotide in Hypothalamic Obesity

NCT04725240

Open-label, single-arm study designed to evaluate the body weight response to setmelanotide administered subcutaneously (SC) daily in participants with hypothalamic obesity (HO).

Hypothalamic Obesity

Rhythm Pharmaceuticals, Inc.18 participantsStarted Jun 2021

San Diego, California, United States • Gainesville, Florida, United States • Saint Paul, Minnesota, United States +2 more locations

RECRUITINGPhase 229 miles

Different Doses of Naronapride Vs. Placebo in Gastroparesis

NCT05621811

This is a double-blind, randomized, multicenter, placebo-controlled, comparative phase II dose-finding trial. The trial will be conducted with four treatment groups in the form of a parallel group comparison and will serve to compare oral treatment with daily doses of 10, 20, or 40 mg Naronapride vs. placebo for the treatment of patients with Gastroparesis.

Gastroparesis

Dr. Falk Pharma GmbH320 participantsStarted Jan 2023

Chula Vista, California, United States • Lomita, California, United States • Clearwater, Florida, United States +19 more locations

Brain Tissue Specimen Collection

Effects of a Virtual Reality Intervention on Mental Health Outcomes and Academic Success in Physical Therapy Students

Open-Label Study of Setmelanotide in Hypothalamic Obesity

Different Doses of Naronapride Vs. Placebo in Gastroparesis

Find Trials by Condition in Tennessee

Predictive Analytics and Behavioral Nudges to Improve Palliative Care in Advanced Cancer

Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

Reduce Crohn's-Associated Diarrhea With Sodium Channel Therapy

Comparative Effectiveness of Operative Versus Non-Operative Treatments for Rotator Cuff Tears

A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participants With PTSD

Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements

A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies

A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006)

Rituximab + Immunotherapy in Follicular Lymphoma

A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-Traumatic Stress Disorder (PTSD)

Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).

Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer

Safety and Immunogenicity of CodaVax-RSV in Seropositive and Seronegative Children

Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy